These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 799564

  • 1. Differential effects of acute and chronic beta-adrenoreceptor blockade on blood pressure and the renin-angiotensin-aldosterone system in essential hypertension.
    Kolloch R, Stumpe KO, Vetter H, Gramann W, Krück F.
    Clin Sci Mol Med Suppl; 1976 Dec; 3():537s-540s. PubMed ID: 799564
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Effect of chronic beta-adrenergic blockade on blood pressure and release of renin, aldosterone and cortisol in essential hypertension (author's transl)].
    Stumpe KO, Vetter H, Hessenbruch V, Düsing R, Kolloch R, Krück F.
    Klin Wochenschr; 1975 Oct 01; 53(19):907-11. PubMed ID: 241876
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Beta-adrenergic receptor blockade as a therapeutic approach for suppressing the renin-angiotensin-aldosterone system in normotensive and hypertensive subjects.
    Blumenfeld JD, Sealey JE, Mann SJ, Bragat A, Marion R, Pecker MS, Sotelo J, August P, Pickering TG, Laragh JH.
    Am J Hypertens; 1999 May 01; 12(5):451-9. PubMed ID: 10342782
    [Abstract] [Full Text] [Related]

  • 7. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease.
    Jensen J, Henik RA, Brownfield M, Armstrong J.
    Am J Vet Res; 1997 May 01; 58(5):535-40. PubMed ID: 9140564
    [Abstract] [Full Text] [Related]

  • 8. Beta-adrenergic receptor blocking drugs, hypertension and plasma renin.
    Morgan TO, Roberts R, Carney SL, Louis WJ, Doyle AE.
    Br J Clin Pharmacol; 1975 Apr 01; 2(2):159-64. PubMed ID: 791319
    [Abstract] [Full Text] [Related]

  • 9. The role of renin in the antihypertensive action of beta-adrenoreceptor blocking agents.
    Stokes GS, Graham RM, Weber MA.
    Drugs; 1976 Apr 01; 11 SUPPL 1():150-6. PubMed ID: 6247
    [Abstract] [Full Text] [Related]

  • 10. Effects of losartan on the renin-angiotensin-aldosterone axis in essential hypertension.
    Bauer IH, Reams GP, Wu Z, Lau-Sieckman A.
    J Hum Hypertens; 1995 Apr 01; 9(4):237-43. PubMed ID: 7595905
    [Abstract] [Full Text] [Related]

  • 11. Changes in plasma renin activity and blood pressure after acute and chronic administration of beta-adrenergic receptor-blocking drugs.
    Morgan T, Carney S, Roberts R.
    Clin Sci Mol Med Suppl; 1975 Jun 01; 2():81s-83s. PubMed ID: 802647
    [Abstract] [Full Text] [Related]

  • 12. Pindolol: effects on blood pressure and plasma renin activity.
    Glassock RJ, Weitzman RE, Bennett CM, Maxwell M, Hamilton B, Winer N, Kirkendall W, Gonasun L.
    Am Heart J; 1982 Aug 01; 104(2 Pt 2):421-5. PubMed ID: 7048878
    [Abstract] [Full Text] [Related]

  • 13. Effect of pindolol and propranolol on plasma renin and aldosterone in patients with renal allograft.
    Wehling M, Kuhlmann U, Záruba K, Largiadèr F, Keusch G, Studer A, Vetter W.
    Clin Nephrol; 1983 Nov 01; 20(5):231-4. PubMed ID: 6360452
    [Abstract] [Full Text] [Related]

  • 14. [Acute and chronic beta-receptor blockade: influence on blood pressure and on the renin-angiotensin-aldosterone system in essential hypertension].
    Stumpe KO, Kolloch R, Gramann W, Vetter H, Krück F.
    Verh Dtsch Ges Inn Med; 1976 Nov 01; 82 Pt 2():1325-8. PubMed ID: 1029991
    [No Abstract] [Full Text] [Related]

  • 15. Relation between plasma renin activity, angiotensin, and aldosterone and blood pressure in mild untreated hypertension.
    Walker WG, Horvath JS, Moore MA, Whelton P, Russell RP.
    Circ Res; 1976 Jun 01; 38(6):470-6. PubMed ID: 1269097
    [Abstract] [Full Text] [Related]

  • 16. [Differences of blood plasma renin activity, angiotensin II and aldosterone levels in essential or secondary hypertension].
    Song AL, Zeng ZP, Tong AL, Lu L, Chen S, Li M, Fu CL, Wang YH, Sun ML.
    Zhonghua Nei Ke Za Zhi; 2012 Apr 01; 51(4):294-8. PubMed ID: 22781950
    [Abstract] [Full Text] [Related]

  • 17. Effect of pressor agents on blood pressure, plasma renin activity and plasma aldosterone concentration in essential hypertension.
    Yamamoto Y.
    Jpn Heart J; 1975 Jul 01; 16(4):404-20. PubMed ID: 1152295
    [Abstract] [Full Text] [Related]

  • 18. Effects of beta-adrenoreceptor blocking drugs on plasma volume. Renin and aldosterone as components of their antihypertensive action.
    Gordon RD.
    Drugs; 1976 Jul 01; 11 SUPPL 1():156-63. PubMed ID: 6248
    [Abstract] [Full Text] [Related]

  • 19. β-Blocker withdrawal is preferable for accurate interpretation of the aldosterone-renin ratio in chronically treated hypertension.
    Browne GA, Griffin TP, O'Shea PM, Dennedy MC.
    Clin Endocrinol (Oxf); 2016 Mar 01; 84(3):325-31. PubMed ID: 26300226
    [Abstract] [Full Text] [Related]

  • 20. Angiotensin II blockade during combined thiazide-beta-adrenoreceptor-blocker treatment.
    Ibsen H, Leth A, McNair A, Giese J.
    Clin Sci (Lond); 1979 Dec 01; 57 Suppl 5():123s-125s. PubMed ID: 396064
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.